For the Inventor, By the Inventor

Enter assignee name

Pittsburgh, PA, United States of America

Duquesne University

USPTO Granted Patents = 145

% Expired Patents = 49.7

CIPO Patents = 7

EPO Patents = 15

Trademarks = 19

Forward Citations = 2,187

Loading Chart...

Loading Chart...

67 inventors (with patents filed for the assignee):

Aleem Gangjee (86 out of 86 patents)

Larry H Matherly (14 out of 14 patents)

Pui-Kai Li (11 out of 20 patents)

4. Kyle W Selcer (8 out of 8 patents)

5. Patrick Juola (5 out of 5 patents)

6. Partha Basu (5 out of 5 patents)

7. Howard M Kingston (4 out of 15 patents)

8. Paula A Witt-Enderby (4 out of 4 patents)

9. Vicki L Davis (4 out of 4 patents)

10. Michael C Ryan (3 out of 50 patents)

11. Robert Hugh Edgar (3 out of 3 patents)

12. John D Hempel (3 out of 3 patents)

13. John Andrew Viator (3 out of 3 patents)

14. Suravi Chakrabarty (3 out of 3 patents)

15. Darlene Monlish (3 out of 3 patents)

Core Competencies:

Antitumor Agents

Pyrimidine Compounds

Bacteriophage Detection

Tyrosine Kinase Inhibitors

Antimitotic Activity

Microtubule Targeting

Prodrug Inhibitors

Chemotherapeutic Agents

Calcium Phosphate

Isonitriles

Folate Transporter

Biometric Identification

145 patents: Sort by Forward Citations

1. 12703863 - AN RNA G-QUADRUPLEX STRUCTURE IN PRE-miRNA-1229 AS A THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE AND VARIOUS CANCERS (2026-08-11),

2. 12657491 - Trend or pattern trigger device (2026-06-16),

3. 11897886 - Pyrazolo[4,3-d]pyrimidines as antitumor agents (2024-02-13),

4. 11840539 - Substituted pyrrolo,-furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof (2023-12-12),

5. 11629370 - Detection of bacteria using bacteriophage (2023-04-18),

6. 11618758 - Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient (2023-04-04),

7. 11605055 - Authorship technologies (2023-03-14),

8. 11572363 - Substituted bicyclic pyrimidine compounds with tubulin and multiple receptor inhibition (2023-02-07),

9. 11465978 - Anthranilic amides and the use thereof (2022-10-11),

10. 11384084 - First-in-class of SHMT2 and MTHFD2 inhibitors as antitumor agents (2022-07-12),

11. 11124520 - Cyclopenta[d]pyrimidines and substituted cyclopenta[d]pyrimidines as antitubulin and microtubule targeting agents, monocyclic pyrimidines as tubulin inhibitors, and pyrrolopyrimidines as targeted antifolates and tubulin and multiple receptor tyrosine kinase inhibitor and antitumor agents (2021-09-21),

12. 11111252 - Pyrimidine compounds and pyrimido indole compounds and methods of use (2021-09-07),

13. 11091500 - Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof (2021-08-17),

14. 11078214 - Monocyclic thieno, pyrido, and pyrrolo pyrimidine compounds and methods of use and manufacture of same (2021-08-03),

15. 11053252 - Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same (2021-07-06),

Company Overview

Duquesne University, located in Pittsburgh, PA, is a prominent institution engaged in advanced research and development in the field of antitumor agents. The university specializes in various core technology topics, including pyrimidine compounds, bacteriophage detection, and tyrosine kinase inhibitors. Its research initiatives focus on innovative approaches to combat cancer through the exploration of antimitotic activity and microtubule targeting, as well as the development of prodrug inhibitors and chemotherapeutic agents, contributing significantly to the medical and pharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

145 Patents

#26 in Pittsburgh, PA

#112 in Pennsylvania

#2,698 in US

#5,612 in the World

Pittsburgh, PA, United States of America

Duquesne University

Forward Citations = 2,187

67 inventors:

Aleem Gangjee (86 out of 86 patents)

Larry H Matherly (14 out of 14 patents)

Pui-Kai Li (11 out of 20 patents)

4. Kyle W Selcer (8 out of 8 patents)

5. Patrick Juola (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Duquesne University. Retrieved from https://idiyas.com/company/duquesne-university

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…